review Open AccessTop 1% cited

Systematic review with meta‐analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory <i>Clostridium difficile</i> infection

Alimentary Pharmacology & Therapeutics · 2017 · Vol. 46(5) · pp. 479–493

Mohammed Nabil Quraishi(NIHR Surgical Reconstruction and Microbiology Research Centre)Monika Widłak(University Hospital Coventry)Neeraj Bhala(NIHR Surgical Reconstruction and Microbiology Research Centre)David Moore(University of Birmingham)Malcolm J Price(University of Birmingham)Nandita Sharma(NIHR Surgical Reconstruction and Microbiology Research Centre)Tariq Iqbal✉(NIHR Surgical Reconstruction and Microbiology Research Centre)

View via DOI Full-text PDF

Abstract

Faecal microbiota transplantation is an effective treatment for recurrent and refractory Clostridium difficile infection, independent of preparation and route of delivery.

Clostridium difficile and Clostridium perfringens research Microscopic Colitis Gut microbiota and healthMedicineClostridium difficileRefractory (planetary science)Internal medicineCochrane LibraryMeta-analysisAdverse effectTransplantationGastroenterologyRandomized controlled trial

MeSH terms

Fecal Microbiota TransplantationClostridium InfectionsCross InfectionDiarrheaHumansVancomycinRandomized Controlled Trials as TopicClostridioides difficileTreatment Outcome

Citations

595

FWCI

35.12

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

ACG Clinical Guideline: Management of Irritable Bowel Syndrome